New York Assembly Bill 9360: Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for obesity, metabolic disorders, and autism-related compulsive eating behaviors.

New York · 2025-2026 session

What it does

Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for obesity, metabolic disorders, and autism-related compulsive eating behaviors.

Latest action

referred to health (2026-01-07)

See how A 9360 affects you on CapitolKey

Browse more bills · CapitolKey home